Ajooni Biotech Limited — QIP/Rights/Pref., 05-02-2025: Issue of Securities

Ajooni Biotech Limited has announced a board meeting regarding the issuance of up to 5,00,00,000 convertible warrants at an issue price of ₹9 each. These warrants will be convertible into an equal number of equity shares at a face value of ₹2 each, with a premium of ₹7. This issuance has been approved by shareholders at the recent Extra Ordinary General Meeting. The proceeds from this preferential allotment are expected to enhance the company’s capital and support its growth initiatives.